- Home
- LFWD vs PHIO Comparison
LFWD vs PHIO Comparison
Compare LFWD & PHIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LFWD
- PHIO
- Stock Information
- Founded
- LFWD 2001
- PHIO 2011
- Country
- LFWD Israel
- PHIO United States
- Employees
- LFWD N/A
- PHIO N/A
- Industry
- LFWD
- PHIO Biotechnology: Pharmaceutical Preparations
- Sector
- LFWD
- PHIO Health Care
- Exchange
- LFWD NYSE
- PHIO Nasdaq
- Market Cap
- LFWD 10.5M
- PHIO 11.9M
- IPO Year
- LFWD 2014
- PHIO N/A
- Fundamental
- Price
- LFWD $0.78
- PHIO $2.74
- Analyst Decision
- LFWD Strong Buy
- PHIO Strong Buy
- Analyst Count
- LFWD 3
- PHIO 2
- Target Price
- LFWD $9.00
- PHIO $9.00
- AVG Volume (30 Days)
- LFWD 804.6K
- PHIO 2.6M
- Earning Date
- LFWD 08-14-2025
- PHIO 08-13-2025
- Dividend Yield
- LFWD N/A
- PHIO N/A
- EPS Growth
- LFWD N/A
- PHIO N/A
- EPS
- LFWD N/A
- PHIO N/A
- Revenue
- LFWD $25,414,000.00
- PHIO N/A
- Revenue This Year
- LFWD $12.04
- PHIO N/A
- Revenue Next Year
- LFWD $40.58
- PHIO N/A
- P/E Ratio
- LFWD N/A
- PHIO N/A
- Revenue Growth
- LFWD 41.92
- PHIO N/A
- 52 Week Low
- LFWD $0.50
- PHIO $0.97
- 52 Week High
- LFWD $4.77
- PHIO $9.79
- Technical
- Relative Strength Index (RSI)
- LFWD 43.98
- PHIO 65.04
- Support Level
- LFWD $0.70
- PHIO $2.31
- Resistance Level
- LFWD $0.84
- PHIO $2.45
- Average True Range (ATR)
- LFWD 0.07
- PHIO 0.19
- MACD
- LFWD 0.03
- PHIO 0.02
- Stochastic Oscillator
- LFWD 44.88
- PHIO 36.76
About LFWD REWALK ROBOTICS LTD
Lifeward Ltd is a medical device company that designs, develops, and commercializes life-changing solutions that span the continuum of care in physical rehabilitation and recovery, delivering functional and health benefits in clinical settings as well as in the home and community. Its product offerings are the ReWalk Exoskeleton, the ReStore Exo-Suit, the MyoCycle FES bikes, and AlterG Anti-Gravity systems. It operates through markets in the United States, Israel, and Germany.
About PHIO Phio Pharmaceuticals Corp.
Phio Pharmaceuticals Corp is a clinical-stage biotechnology company whose proprietary INTASYL self-delivering RNAi technology platform is designed to make immune cells more effective in killing tumor cells. The Company is developing therapeutics that are designed to leverage INTASYL to precisely target specific proteins that reduce the body's ability to fight cancer, without the need for specialized formulations or drug delivery systems.